New and Emerging Treatments in Geriatric Pharmacology – Eric Christianson

*** Proof of Product ***

Exploring the Essential Features of “New and Emerging Treatments in Geriatric Pharmacology – Eric Christianson”

Discover the evolving landscape of precision medicine, novel psychotropic agents, and diabetes management in our cutting-edge online course. From exploring genetic variations and pharmacogenomics to navigating the appropriate use of new medications and implementing the latest diabetes guidelines, equip yourself with essential knowledge and skills to revolutionize prescribing patterns and patient care.

Speaker

Eric Christianson, PharmD, BCGP, BCPS, is a PharmD, board-certified in geriatrics and pharmacotherapy, an Amazon best-selling author, podcaster, and national speaker. Author of Meded101 Guide to Nursing Pharmacology, Perils of Polypharmacy, and Meded101 Guide to Drug Food Interactions, he is well known for his expertise in passion. Eric found his calling in geriatrics and medication management, and for years has worked as a consultant pharmacist for long-term care and assisted living facilities as well as working with patients and families doing medication therapy management. Eric has been featured in the Wall Street Journal, American Journal of Nursing, National Association Directors of Nursing, Pharmacy Times, and Pharmacy Today. Eric’s goal is to teach as many individuals as possible about the safe, economical, and appropriate use of medications!

Speaker Disclosures:

Financial: Eric Christianson is the founder, administrator, and author of Med Ed 101, Inc. and receives royalties as a published author. He is the host of Real Life Pharmacology podcast. Eric Christianson receives a speaking honorarium from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Eric Christianson has no relevant non-financial relationships.

Objectives

1. Analyze how precision medicine and pharmacogenomics influences prescribing patterns.
2. Determine appropriate use of new psychotropic medications.
3. Implement diabetes management protocols using the latest guidelines. 

Outline

Precision Medicine and Pharmacogenomics

• Rapid/extensive metabolizer vs. Slow/poor metabolizer
• Prodrugs – opposite effects
• Genetic Variations

Novel Psychotropic Agents

• Brexpiprazole (Rexulti)
• Aducanumab (Aduhelm)
• Lecanemab-irmb (Leqembi)
• Donanemab

Diabetes Updates

• Cognitive Decline
• Technology – CGMs
• Interfering Substances
• Weight Loss Meds

Target Audience

• Nurses
• Nurse Practitioners
• Physician Assistants
• Physicians
• Pharmacists
• Prescribers

Please see the full list of alternative group-buy courses available here: https://lunacourse.com/shop/